Sort
261,768 grants matching “gene therapy”
Mechanism, Regulation and Application of miRNA pathway in cancer
$1,200,709Shuo Gu · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
$1,200,531Xiaodong Cheng · University Of Texas Hlth Sci Ctr Houston · R01 · FY2018 · AI
Dynamic State Space Modeling of Cancer Cell Response to Therapy
$1,200,478Garry P Nolan · University Of Southern California · U54 · FY2010 · CA
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
$1,200,379David A Williams · Boston Children'S Hospital · OT2 · FY2020 · HL
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
$1,200,301Douglas F Nixon · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
Gene Therapy Resource Program Pharmacology-Toxicology Core Lab
$1,200,000Fraser Wright · Lovelace Biomedical & Environmental Research Institute · N01 · FY2014 · HL
Collaborative Research: MODULUS: Uncovering and re-engineering chromatin modification circuits that dictate epigenetic cell memory
$1,200,000Domitilla Del Vecchio · Massachusetts Institute Of Technology · · FY2020 · BIO
CER on CAM Antioxidant Therapies (CERCAT)
$1,200,000Balz B Frei · Oregon State University · P01 · FY2008 · AT
CER on CAM Antioxidant Therapies (CERCAT)
$1,200,000Balz B Frei · Oregon State University · P01 · FY2010 · AT
Cellular and molecular mediators of fibrosis in the development of urinary tract dysfunction
$1,200,000William Ricke · University Of Wisconsin-Madison · U54 · FY2019 · DK
CER on CAM Antioxidant Therapies (CERCAT)
$1,200,000Balz B Frei · Oregon State University · P01 · FY2009 · AT
Center for Herbal Research on Colorectal Cancer
$1,199,999Chun-Su Yuan · University Of Chicago · P01 · FY2009 · AT
Novel Small-Molecule Inhibitors of Bcl-2/Bcl-xL Protein*
$1,199,944University Of Michigan At Ann Arbor · U19 · FY2005 · CA
Signal Transduction Events and the Regulation of Cell Growth
$1,199,893Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2021 · CA
New statistical methods for neutral phylogenetic reconstruction
$1,199,723Volodymyr M Minin · University Of Washington · · FY2009 · MPS
SBIR Phase II: Preclinical Validation of an Ocular Antioxidant Enhancing Gene Delivery Vehicle for Dry Macular Degeneration
$1,199,722Ramaswamy L Ramkumar · Oculogenex · · FY2022 · TIP
Novel Molecular Therapies of Prostate Cancer
$1,199,386Dario C. Altieri · Wistar Institute · P01 · FY2011 · CA
PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate BiomarkersTask Order Title: Sulforaphane for the Prevention of Malignant Mesothelioma
$1,199,274Joseph Testa · Research Inst Of Fox Chase Can Ctr · N01 · FY2023 · CA
Signaling in the retina and retinal pigment epithelium
$1,199,202Thomas Redmond · National Eye Institute · ZIA · FY2020 · EY
FORMULATION OF RATIONAL THERAPY OF NEPHROLITHIASIS
$1,199,141University Of Texas Sw Med Ctr/Dallas · P01 · FY2003 · DK
FORMULATION OF RATIONAL THERAPY OF NEPHROLITHIASIS
$1,199,141University Of Texas Sw Med Ctr/Dallas · P01 · FY2002 · DK
Oral Microbial and Immunological Characterization of Patients with Immune Dysfun
$1,199,034Niki Moutsopoulos · National Institute Of Dental & Craniofacial Research · ZIA · FY2018 · DE
Gene Therapy for Metabolic Disorders
$1,198,865Chester B Whitley · University Of Minnesota · P01 · FY2014 · HD
Gene Therapy for Metabolic Disorders
$1,198,672Chester B Whitley · University Of Minnesota · P01 · FY2016 · HD
Lymphoma Disease Discovery and Definition
$1,198,546Elaine Jaffe · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA